Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201107017 Principal Investigator: Tan, Benjamin
Title: A Phase I Dose-Escalation Trial of Biweekly Intraperitoneal Oxaliplatin with Systemic Capecitabine and Bevacizumab Following Cytoreduction in Patients with Peritoneal Carcinomatosis from Appendiceal or Colorectal Cancer
Description: The main purpose of this research is to evaluate an intraperitoneal treatment for cancer following a surgical attempt to remove as much or all of the cancer as possible. The goals of this study are to determine the safety and side effects of this treatment, and to learn the maximum tolerated dose (...MORE
___________________________________________________________________________________________________
 Number: CTSU S1406 Principal Investigator: Tan, Benjamin
Title: Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Description: The purpose of this study is to compare any good and bad effects of using vemurafenib along with the usual chemotherapy, cetuximab and irinotecan,to using the usual chemotherapy approach alone in pateients with BRAF mutation positive colorectal cancer....MORE
___________________________________________________________________________________________________
 Number: CTSU N1048 Principal Investigator: Tan, Benjamin
Title: A Phase II/III trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision (N1048)
Description: This trial studies how well chemotherapy alone compared to chemotherapy plus radiation therapy works in treating patients with rectal cancer undergoing surgery. ...MORE
___________________________________________________________________________________________________
 Number: CTSU E7208 Principal Investigator: Tan, Benjamin
Title: A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab, in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy
Description: The purpose of the study is to determine whether an investigational drug, ramucirumab, is safe and effective when given with irinotecan and cetuximab....MORE
___________________________________________________________________________________________________
 Number: 201409007 Principal Investigator: Lockhart, A. Craig
Title: A Randomized, Double-Blind Study of Ruxolitinib or Placebo in Combination with Regorafenib in Subjects with Relapsed or Refractory Metastatic Colorectal Cancer
Description: The purpose of this study is to find out if giving regorafeinib in combination with ruxolitinib is better at treating colorectal cancer than regorafenib alone....MORE
___________________________________________________________________________________________________
 Number: 201202001 Principal Investigator: Zuckerman, Darryl
Title: A Phase III Clinical Trial Evaluating TheraSphere in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy
Description: The purpose of this research study is to examine whether adding treatment with TheraSphere early in the current standard for second-line chemotherapy treatment of metastatic colorectal cancer is better than the current treatment alone. Better means slowing or stopping the growth of liver tumors ...MORE
___________________________________________________________________________________________________
 Number: NCICCTG 9673 Principal Investigator: Singh, Preet
Title: A Multi-Institutional Phase 2 Study of Nivolumab in Refractory Metastatic Squamous Cell Carcinoma of the Anal Canal
___________________________________________________________________________________________________